Appendix D
Venture-funded Firms: Data from Hoover’s Small Business Database and VentureSource
Company |
Venture Capital (Thousands of Dollars) |
Rounds |
Last Round Date |
|||
Advanced Tissue Sciences, Inc. |
90,578.0 |
3 |
11/2/2001 |
|||
Albion Instruments |
8,968.0 |
7 |
1/1/1990 |
|||
Ambion, Inc. |
10,500.0 |
1 |
5/1/2003 |
|||
Applied Immune Sciences, Inc. |
44,060.1 |
11 |
1/1/1991 |
|||
Applied Molecular Evolution, Inc. |
32,350.0 |
6 |
6/1/2000 |
|||
Aronex Pharmaceuticals, Inc. |
9,496.0 |
3 |
3/2/1999 |
|||
Aviron (FKA: Vector Pharmaceuticals, Inc.) |
87,340.1 |
4 |
11/1/2000 |
|||
Argus Software, Inc. |
3,815.9 |
4 |
7/30/1999 |
|||
Aurora Biosciences Corporation |
18,720.0 |
3 |
12/15/1996 |
|||
AcryMed, Inc. |
3,500.0 |
4 |
3/1/2003 |
|||
Alexion Pharmaceuticals, Inc. |
5,800.0 |
2 |
12/23/1994 |
|||
Automatix, Inc. |
21,850.0 |
7 |
12/1/1987 |
|||
Aastrom Biosciences, Inc. |
36,384.9 |
8 |
10/30/2002 |
|||
ABIOMED, Inc. |
35,800.0 |
1 |
3/27/2007 |
|||
Adolor Corporation |
137,483.0 |
7 |
5/31/2001 |
|||
Alkermes, Inc. |
12,384.3 |
5 |
10/1/1992 |
|||
Amylin Pharmaceuticals, Inc. |
84,200.0 |
9 |
9/20/2002 |
|||
ARIAD Pharmaceuticals, Inc. |
56,075.0 |
3 |
5/20/2003 |
|||
Aradigm Corporation |
139,454.0 |
9 |
3/7/2003 |
|||
Altea Therapeutics |
54,546.9 |
4 |
6/15/2007 |
|||
Amedica Corporation |
44,569.0 |
4 |
4/27/2007 |
|||
Amnis Corporation |
18,750.0 |
3 |
3/27/2006 |
|||
Ancile Pharmaceuticals, Inc. |
30,365.0 |
6 |
10/27/2002 |
First Round Date |
Status |
Ticker Symbol |
Last Known Date |
Annual Revenue (Millions of Dollars) |
Number of Employees |
Profit/Loss |
4/1/1996 |
Out of business |
|
2003 |
|
|
|
6/1/1986 |
Sold |
|
2000 |
|
|
|
5/1/2003 |
Sold |
|
2006 |
13.6 |
|
|
11/1/1984 |
Sold |
|
1995 |
|
|
|
3/1/1990 |
Sold |
|
|
10.2 |
|
|
7/1/1991 |
Sold |
|
2001 |
|
|
|
6/1/1992 |
Sold |
|
|
|
|
|
1/1/1995 |
Foreign |
|
|
|
|
|
3/7/1996 |
Foreign |
|
|
|
|
|
4/1/1994 |
n/a |
|
|
|
|
|
11/12/1993 |
NASDAQ |
ALXN |
|
1.6 |
241 |
(131.5) |
1/1/1980 |
n/a |
|
|
|
|
|
8/18/1989 |
NASDAQ |
ASTM |
|
0.7 |
|
(17.6) |
3/27/2007 |
NASDAQ |
AMMD |
|
50.7 |
324 |
|
11/1/1994 |
NASDAQ |
ADLR |
|
15.9 |
179 |
(69.7) |
10/1/1987 |
NASDAQ |
alks |
|
240.0 |
830 |
9.9 |
11/1/1987 |
NASDAQ |
AMLN |
|
510.9 |
1,550 |
(218.9) |
2/1/1991 |
NASDAQ |
ARIA |
|
0.9 |
108 |
(61.9) |
10/16/1992 |
OTC |
ARDM |
|
4.8 |
103 |
(13.0) |
11/21/2002 |
private |
|
|
|
|
|
1/28/2004 |
private |
failed IPO |
2007 |
0.1 |
33 |
(6.3) |
2/28/2000 |
private |
|
|
3.5 |
37 |
|
11/4/1998 |
private |
|
|
3.2 |
30 |
|
Company |
Venture Capital (Thousands of Dollars) |
Rounds |
Last Round Date |
||
Artecel Sciences, Inc. |
4,135.2 |
2 |
5/29/2002 |
||
Atherotech, Inc. |
21,399.9 |
4 |
1/31/2005 |
||
Avocet Medical, Inc. |
36,801.0 |
3 |
7/1/2001 |
||
BioCryst Pharmaceuticals, Inc. |
39,964.9 |
3 |
9/30/2007 |
||
BioMarin Pharmaceutical, Inc. |
53,000.0 |
2 |
5/16/2001 |
||
BIOQUAL, Inc. (FKA: Diagnon Corporation) |
1,351.0 |
2 |
5/1/1983 |
||
Biosearch, Inc. |
1,800.0 |
2 |
12/1/1983 |
||
Biosym Technologies, Inc. |
5,168.0 |
3 |
4/1/1992 |
||
BioTransplant, Inc. |
9,561.0 |
3 |
6/30/2001 |
||
Cambridge Neuroscience, Inc. (FKA: Synax, Inc.) |
35,879.0 |
9 |
6/21/1997 |
||
Cell Based Delivery, Inc. |
11,175.0 |
2 |
5/7/2002 |
||
Centaur Pharmaceuticals, Inc. |
63,451.0 |
7 |
11/2/2001 |
||
Cephalon, Inc. |
40,037.8 |
8 |
2/25/1999 |
||
Chektec Corporation |
846.0 |
3 |
4/1/1993 |
||
Clarus Medical LLC (Medilase, Inc.) |
27,548.9 |
12 |
5/1/1997 |
||
Clontech Laboratories, Inc. |
28,836.0 |
2 |
7/1/1998 |
||
CoCensys, Inc. |
24,071.0 |
9 |
1/7/1997 |
||
Cognetix, Inc. |
19,010.0 |
2 |
6/1/2006 |
||
CompuCyte Corporation |
18,700.0 |
3 |
8/1/1999 |
||
Conductus, Inc. |
45,699.9 |
6 |
3/27/2002 |
||
Control Delivery Systems, Inc. (AKA: CDS, Inc.) |
34,500.0 |
1 |
8/22/2000 |
||
COR Therapeutics, Inc. |
20,652.0 |
6 |
1/1/1998 |
||
Corixa Corporation |
157,581.1 |
6 |
6/10/2003 |
||
Cortex Pharmaceuticals, Inc. |
9,100.0 |
2 |
7/1/1989 |
||
Creative BioMolecules, Inc. |
23,284.0 |
18 |
7/1/1995 |
||
Cryolife, Inc. |
3,057.0 |
3 |
6/1/1988 |
||
Cryopharm Corporation |
30,346.0 |
10 |
1/1/1994 |
||
Cubist Pharmaceuticals, Inc. |
36,283.0 |
5 |
9/23/1998 |
||
CuraGen Corporation |
26,790.0 |
2 |
9/1/1999 |
||
CytoLogix Corporation |
46,850.0 |
5 |
5/29/2002 |
||
Cytomation, Inc. |
14,293.0 |
2 |
6/8/2001 |
||
Cytyc Corporation (FKA: Generitech Corporation) |
35,154.9 |
4 |
5/1/1995 |
||
Dharmacon Research, Inc. |
5,700.0 |
1 |
8/23/2002 |
||
Digirad Corporation (FKA: Aurora Technologies) |
75,320.0 |
9 |
4/24/2002 |
||
DiscoveRx Corporation, Ltd. |
28,406.0 |
5 |
2/20/2007 |
||
Discovery Laboratories, Inc. |
13,211.0 |
2 |
6/20/2003 |
||
Displaytech, Inc. |
70,225.1 |
5 |
3/12/2006 |
||
Edenspace Systems Corporation |
5,250.0 |
1 |
4/23/2007 |
||
EKOS Corporation |
85,900.4 |
8 |
6/27/2007 |
||
Endocyte, Inc. |
60,700.2 |
4 |
3/23/2007 |
||
Epicyte Pharmaceutical, Inc. |
22,200.0 |
4 |
4/16/2001 |
||
EpiGenesis Pharmaceuticals, Inc. |
35,956.2 |
4 |
3/7/2007 |
||
Epoch Biosciences (FKA:MicroProbe Corporation) |
30,030.2 |
13 |
7/1/1993 |
First Round Date |
Status |
Ticker Symbol |
Last Known Date |
Annual Revenue (Millions of Dollars) |
Number of Employees |
Profit/Loss |
11/29/2000 |
private |
|
|
0.1 |
1 |
|
3/31/1999 |
private |
|
|
|
|
|
10/1/1996 |
private |
|
|
|
|
|
8/1/1992 |
NASDAQ |
|
|
6.2 |
52 |
(43.6) |
1/1/1998 |
NASDAQ |
|
|
84.2 |
314 |
(28.5) |
7/1/1981 |
private |
|
|
19.4 |
150 |
|
4/1/1983 |
private |
|
|
4.6 |
65 |
|
10/1/1986 |
Sold |
|
|
|
|
|
10/1/1995 |
Out of business |
|
2003 |
|
|
|
1/1/1986 |
Sold |
|
|
|
|
|
3/7/2002 |
Out of business |
|
|
|
|
|
12/1/1992 |
Out of business |
|
2002 |
|
|
|
10/1/1987 |
NASDAQ |
CEPH |
|
18,641.1 |
2,895 |
144.8 |
12/1/1988 |
Outof business |
|
|
|
|
|
1/6/1989 |
private |
|
|
0.2 |
3 |
|
7/1/1997 |
private |
|
|
17.0 |
175 |
|
2/1/1989 |
Sold |
|
|
|
|
|
8/1/2001 |
Out of business |
|
|
|
|
|
4/1/1996 |
private |
|
|
6.7 |
28 |
|
9/1/1987 |
Sold |
|
|
|
|
|
8/22/2000 |
Sold |
|
2005 |
17.2 |
26 |
|
3/16/1988 |
Sold |
|
2002 |
|
|
|
12/2/1994 |
Sold |
|
2005 |
|
|
|
5/1/1988 |
AMEX |
COR |
|
1.2 |
26 |
(16.2) |
5/1/1982 |
NASDAQ |
CRIS |
|
16.7 |
68 |
(8.8) |
1/1/1986 |
NYSE |
CRY |
|
81.3 |
363 |
0.4 |
1/1/1988 |
private |
|
|
2.5 |
25 |
|
9/1/1992 |
NASDAQ |
CBST |
|
194.8 |
410 |
(0.4) |
3/1/1997 |
NASDAQ |
CRGN |
|
39.6 |
666 |
(59.8) |
1/1/1997 |
private |
|
|
|
|
|
5/1/1997 |
Sold |
|
|
|
|
|
1/1/1987 |
Sold |
|
2006 |
608.0 |
1,500 |
139.5 |
8/23/2002 |
private |
|
|
10.1 |
120 |
|
5/30/1995 |
NASDAQ |
DRAD |
|
71.9 |
601 |
(6.3) |
2/1/1999 |
private |
|
|
3.3 |
40 |
|
11/5/2002 |
NASDAQ |
|
|
0.0 |
160 |
(46.3) |
4/11/2000 |
IPO |
|
2002 |
3.2 |
47 |
|
4/23/2007 |
private |
|
|
0.7 |
10 |
|
10/1/1996 |
private |
|
|
9.5 |
99 |
|
7/1/2001 |
private |
|
|
3.3 |
40 |
|
7/1/1996 |
Sold |
|
2004 |
|
|
|
10/1/1997 |
private |
|
|
|
|
|
3/1/1986 |
Sold |
|
2004 |
|
|
|
Company |
Venture Capital (Thousands of Dollars) |
Rounds |
Last Round Date |
||
EraGen Biosciences, Inc. (FKA: Sulfonics, Inc.) |
32,647.0 |
3 |
3/15/2007 |
||
Exogene Corporation |
7,115.1 |
5 |
7/1/1993 |
||
Fluorous Technologies, Inc. (AKA: FTI) |
3,650.0 |
2 |
5/23/2003 |
||
Genaera Corporation (FKA: Magainin Pharmaceuticals) |
18,106.0 |
5 |
10/1/1998 |
||
Genaissance Pharmaceuticals, Inc. |
75,749.9 |
4 |
11/4/2004 |
||
Genelabs Technologies, Inc. |
34,949.4 |
8 |
6/29/2006 |
||
GeneMedicine, Inc. |
8,900.0 |
2 |
7/13/1994 |
||
Genetic Therapy, Inc. |
13,989.0 |
8 |
7/1/1994 |
||
GenPharm International, Inc. |
18,989.1 |
8 |
2/29/2000 |
||
Geron Corporation |
42,074.8 |
5 |
1/1/1996 |
||
Gilead Sciences, Inc. |
32,060.0 |
6 |
8/1/1992 |
||
Gliatech, Inc. |
32,596.1 |
7 |
6/1/1995 |
||
Hauser Chemical Research, Inc. |
1,893.0 |
3 |
12/7/1990 |
||
Hawaii Biotech, Inc. |
16,500.0 |
5 |
12/26/2006 |
||
Houston Biotechnology, Inc. |
3,240.0 |
2 |
5/1/1986 |
||
Hypres, Inc. |
39,841.0 |
20 |
12/31/2002 |
||
Icagen, Inc. |
96,700.7 |
7 |
2/1/2007 |
||
Illumigen Biosciences, Inc. |
7,950.0 |
8 |
7/6/2007 |
||
Illumina, Inc. |
36,567.0 |
2 |
11/1/1999 |
||
Immtech Pharmaceuticals, Inc. (FKA: Immtech International) |
2,509.0 |
3 |
2/14/1994 |
||
ImmuLogic Pharmaceutical Corporation |
29,844.0 |
5 |
2/22/1993 |
||
Immunicon Corporation |
106,800.4 |
7 |
6/29/2005 |
||
ImmunoGen, Inc. |
21,934.0 |
7 |
1/1/1989 |
||
Immusol, Inc. |
23,500.0 |
2 |
9/24/2003 |
||
IntraTherapeutics, Inc. (FKA: Cardia Catheter Company) |
32,224.2 |
8 |
3/31/2000 |
||
Invitrogen Corporation |
15,000.0 |
1 |
6/20/1997 |
||
Iomai Corporation |
80,570.0 |
9 |
10/25/2006 |
||
Irvine Sensors Corporation |
2,650.0 |
3 |
6/10/2003 |
||
Isis Pharmaceuticals |
17,490.0 |
6 |
8/11/1994 |
||
Isolab, Inc. |
2,744.0 |
2 |
6/28/1990 |
||
ISTO Technologies, Inc. |
25,725.0 |
5 |
8/3/2007 |
||
Kurzweil Applied Intelligence, Inc. |
26,122.1 |
13 |
1/1/1993 |
||
Large Scale Biology Corp. (FKA: Biosource Genetics Corp) |
11,675.1 |
6 |
3/1/1998 |
||
Laser Diagnostic Technology, Inc. |
13,310.9 |
5 |
11/30/2001 |
||
Laserscope |
24,045.4 |
8 |
9/1/1987 |
||
LeukoSite, Inc. |
32,613.1 |
8 |
7/1/1998 |
||
LifeSpan BioSciences, Inc. |
19,000.0 |
1 |
4/17/2001 |
||
Linguagen Corporation |
20,212.0 |
4 |
5/23/2006 |
||
Lucent Medical Systems, Inc. |
6,700.0 |
2 |
9/25/1998 |
||
Lynx Therapeutics, Inc. |
72,200.4 |
5 |
9/25/2003 |
||
Markwell Medical Institute, Inc. |
882.0 |
5 |
5/1/1987 |
||
MediChem Research Inc. |
35,000.0 |
1 |
6/28/1999 |
||
Medinox, Inc. |
21,199.8 |
2 |
1/8/2002 |
First Round Date |
Status |
Ticker Symbol |
Last Known Date |
Annual Revenue (Millions of Dollars) |
Number of Employees |
Profit/Loss |
10/6/2005 |
private |
|
|
|
|
|
10/1/1988 |
Sold |
|
1996 |
|
|
|
6/20/2000 |
private |
|
|
2.0 |
15 |
|
3/1/1988 |
NASDAQ |
GENR |
|
0.9 |
46 |
(21.2) |
8/1/1998 |
Sold |
|
2005 |
|
|
|
10/1/1984 |
NASDAQ |
GNLB |
|
11.2 |
66 |
(8.7) |
10/1/1992 |
private |
|
|
14.9 |
110 |
|
8/1/1988 |
private |
|
|
1.0 |
15 |
|
2/29/2000 |
Sold |
|
|
|
|
|
7/10/1992 |
NASDAQ |
GERN |
|
3.3 |
90 |
(31.4) |
8/1/1987 |
NASDAQ |
GILD |
|
3,026.1 |
2,525 |
(1,190.0) |
7/1/1988 |
Sold |
|
2000 |
|
|
|
4/1/1988 |
Out of business |
|
|
|
|
|
6/7/2002 |
private |
|
|
5.1 |
65 |
|
10/1/1985 |
Sold |
|
|
|
|
|
7/1/1983 |
private |
|
|
8.0 |
33 |
|
10/1/1995 |
NASDAQ |
ICGN |
|
8.4 |
72 |
(24.8) |
5/1/2000 |
private |
|
|
1.5 |
10 |
|
11/30/1998 |
NASDAQ |
ILMN |
|
184.5 |
277 |
40.0 |
12/21/1992 |
AMEX |
IMM |
|
4.3 |
27 |
(11.3) |
5/1/1987 |
Out of business |
|
2002 |
|
|
|
7/1/1988 |
NASDAQ |
IMMC |
|
8.7 |
107 |
(24.0) |
6/1/1981 |
NASDAQ |
IMGN |
|
38.2 |
192 |
(19.0) |
6/1/2001 |
Sold |
|
|
|
|
|
10/7/1991 |
Sold |
|
2001 |
|
|
|
6/20/1997 |
NASDAQ |
|
|
1,263.5 |
4,835 |
(191.0) |
1/1/1998 |
NASDAQ |
IOMI |
|
1.5 |
66 |
(31.8) |
10/1/1997 |
NASDAQ |
IRSN |
|
30.8 |
166 |
(8.5) |
2/1/1989 |
NASDAQ |
ISIS |
|
24.5 |
258 |
(45.9) |
5/1/1987 |
Foreign |
|
|
|
|
|
3/1/2000 |
private |
|
|
1.6 |
24 |
|
5/1/1984 |
private |
|
|
|
|
|
12/1/1987 |
private |
|
|
0.8 |
20 |
|
1/1/1994 |
Foreign |
|
|
|
|
|
3/1/1983 |
Sold |
|
2006 |
|
|
|
9/1/1994 |
Sold |
|
1999 |
|
|
|
4/17/2001 |
private |
|
|
3.3 |
40 |
|
12/30/2003 |
private |
|
|
|
|
|
7/1/1997 |
private |
|
|
0.5 |
7 |
|
2/15/1994 |
Sold |
2007 |
|
|
|
|
6/1/1981 |
Out of business |
|
|
|
|
|
6/28/1999 |
private |
|
|
|
|
|
6/15/1999 |
private |
|
|
|
|
|
Company |
Venture Capital (Thousands of Dollars) |
Rounds |
Last Round Date |
||
MediSpectra, Inc. |
58,970.0 |
8 |
7/21/2006 |
||
Meridian Instruments, Inc. |
3,557.0 |
4 |
10/1/1993 |
||
Message Pharmaceuticals, Inc. |
11,142.5 |
8 |
4/14/2004 |
||
MIICRO, Inc. |
6,840.0 |
4 |
9/26/2001 |
||
MIDI |
2.0 |
8,250 |
5/3/2004 |
||
Moberg Medical, Inc. (AKA: Moberg Research, Inc.) |
5,473.8 |
6 |
4/1/1997 |
||
Molecular Dynamics, Inc. |
22,717.0 |
7 |
7/1/1994 |
||
Myogen, Inc. |
191,452.8 |
6 |
10/13/2004 |
||
Nanosphere, Inc. |
80,130.1 |
5 |
5/16/2006 |
||
NeoGenesis, Inc. |
22,999.9 |
1 |
6/21/2001 |
||
Nereus Pharmaceuticals, Inc. |
127,345.6 |
8 |
8/9/2007 |
||
NeuroControl Corporation |
22,800.0 |
9 |
1/4/2001 |
||
Neurocrine Biosciences, Inc. |
21,499.9 |
6 |
5/23/1996 |
||
Neuron Therapeutics, Inc. (FKA: ICTUS Pharmaceuticals) |
28,717.0 |
4 |
12/7/2001 |
||
NimbleGen Systems, Inc. |
73,250.5 |
8 |
1/2/2007 |
||
Nimbus Medical, Inc. |
9,635.1 |
3 |
7/1/1986 |
||
Octagen Corporation |
4,800.0 |
2 |
3/6/2000 |
||
Ontogen |
24,945.0 |
5 |
10/13/2000 |
||
Onyx Pharmaceuticals, Inc. |
70,200.2 |
6 |
5/9/2002 |
||
Organ Recovery Systems |
13,999.8 |
1 |
7/29/2004 |
||
Orquest, Inc. |
42,814.8 |
5 |
10/16/2001 |
||
Palatin Technologies |
45,700.0 |
3 |
1/30/2004 |
||
Panacos Pharmaceuticals, Inc. |
26,550.0 |
3 |
6/28/2007 |
||
Perlan Therapeutics, Inc. |
5,227.0 |
3 |
12/27/2001 |
||
Pharmacopeia Drug Discovery, Inc. |
8,472.0 |
1 |
8/11/2005 |
||
PharmaSonics, Inc. |
22,700.0 |
4 |
6/30/2002 |
||
Pharmavene, Inc. |
13,044.0 |
3 |
6/1/1996 |
||
PHT Corporation (AKA: Personal Health Technologies Corp.) |
48,250.2 |
6 |
10/18/2004 |
||
Phylos, Inc. |
25,100.0 |
1 |
11/30/2000 |
||
Physical Optics Corporation |
3,337.0 |
4 |
8/1/1990 |
||
Physical Sciences, Inc. |
492.0 |
2 |
7/1/1995 |
||
Premier Laser Systems, Inc |
6,145.0 |
4 |
1/1/1997 |
||
Progenics Pharmaceuticals, Inc. |
21,448.0 |
2 |
12/27/2005 |
||
Promega Corporation |
5,250.0 |
4 |
5/27/1993 |
||
PRP, Inc. |
384.0 |
2 |
1/1/1996 |
||
Proteome, Inc. |
8,100.0 |
1 |
12/1/1999 |
||
Quantum Dot Corporation (AKA: Q Dot) |
39,150.0 |
3 |
8/10/2005 |
||
Quantum Magnetics, Inc. |
3,800.0 |
3 |
7/1/1997 |
||
Replidyne, Inc. |
126,500.1 |
6 |
8/17/2005 |
||
Repligen Corporation |
12,234.0 |
3 |
5/1/1985 |
||
RiboGene, Inc. (FKA: Transgene) |
48,233.2 |
15 |
2/1/1997 |
||
Sangamo Biosciences |
16,950.0 |
3 |
12/31/2001 |
||
Sangart, Inc. |
50,353.0 |
2 |
4/4/2007 |
First Round Date |
Status |
Ticker Symbol |
Last Known Date |
Annual Revenue (Millions of Dollars) |
Number of Employees |
Profit/Loss |
6/1/1996 |
private |
|
|
1.6 |
21 |
|
5/1/1983 |
Sold |
|
|
|
|
|
1/1/1998 |
Out of business |
|
2004 |
|
|
|
10/31/1997 |
private |
|
|
1.6 |
20 |
|
5/19/2005 |
private |
|
|
1.3 |
25 |
|
1/1/1992 |
private |
|
|
|
|
|
9/1/1987 |
Sold |
|
1998 |
|
|
|
10/5/1998 |
Sold |
|
2006 |
|
|
|
1/25/2000 |
NASDAQ |
NSPH |
|
1.1 |
50 |
113.0 |
1/9/2001 |
Sold |
|
2005 |
|
|
|
7/29/1998 |
private |
|
|
9.3 |
29 |
|
3/3/1994 |
private |
|
|
|
|
|
9/25/1992 |
NASDAQ |
NBIX |
|
39.2 |
588 |
(107.2) |
10/1/1998 |
private |
|
|
|
|
|
9/1/2000 |
Sold |
|
|
|
|
|
3/1/1988 |
Sold |
|
1996 |
|
|
|
4/1/1998 |
private |
|
|
|
|
|
5/19/1992 |
Out of business |
|
2003 |
|
|
|
4/24/1992 |
NASDAQ |
|
|
0.3 |
125 |
(92.7) |
1/20/2003 |
private |
|
|
2.4 |
27 |
|
6/8/1994 |
Sold |
|
2003 |
|
|
|
11/1/1996 |
AMEX |
PTN |
|
14.4 |
85 |
(27.8) |
11/4/2000 |
NASDAQ |
PANC |
|
0.3 |
32 |
(38.1) |
6/4/1999 |
private |
|
|
1.2 |
14 |
|
8/11/2005 |
NASDAQ |
PCOP |
|
16.9 |
150 |
(27.8) |
2/1/1997 |
Out of business |
|
|
|
|
|
4/1/1993 |
Sold |
|
|
|
|
|
11/3/1999 |
private |
|
|
8.4 |
80 |
|
11/30/2000 |
private |
|
|
1.7 |
18 |
|
8/1/1987 |
private |
|
|
30.0 |
150 |
|
5/9/1995 |
private |
|
|
12.4 |
150 |
|
4/1/1994 |
Out of business |
|
|
|
|
|
12/1/1995 |
NASDAQ |
PGNX |
|
69.9 |
149 |
(21.6) |
10/1/1982 |
private |
|
|
175.0 |
850 |
|
4/1/1996 |
private |
|
|
6.8 |
130 |
|
12/1/1999 |
private |
|
|
|
|
|
1/1/1999 |
Sold |
|
2005 |
|
|
|
10/15/1995 |
Out of business |
|
|
|
|
|
2/21/2002 |
NASDAQ |
RDYN |
|
16.0 |
85 |
(29.3) |
11/1/1981 |
NASDAQ |
RGEN |
|
14.1 |
45 |
(0.9) |
1/1/1990 |
Sold |
|
1999 |
|
|
|
6/1/1996 |
NASDAQ |
SGMO |
|
7.9 |
62 |
(17.9) |
10/31/2004 |
private |
|
|
7.3 |
35 |
|
Company |
Venture Capital (Thousands of Dollars) |
Rounds |
Last Round Date |
|||
Scios Nova, Inc. (F.K.A Scios Inc) California Biotechnology) |
5,425.0 |
1 |
6/1/1982 |
|||
Secretech |
800.0 |
2 |
10/1/1990 |
|||
Selective Genetics, Inc. (FKA: Prizm Pharmaceuticals, Inc.) |
56,867.0 |
14 |
12/1/2003 |
|||
Sepracor, Inc. |
16,892.0 |
8 |
2/22/1993 |
|||
Signal Pharmaceuticals, Inc. |
44,543.7 |
10 |
12/1/1999 |
|||
Spire Corporation |
3,750.0 |
3 |
1/1/1987 |
|||
Stratagene Cloning Systems |
1,873.0 |
2 |
12/31/1992 |
|||
Structural Bioinformatics, Inc. |
46,371.7 |
4 |
3/22/2000 |
|||
Sunesis Pharmaceuticals, Inc. (FKA: Mosaic Pharmaceutical) |
163,338.1 |
8 |
5/30/2007 |
|||
Synaptic Pharmaceutical Corporation (FKA:Neurogenetic Corp) |
89,772.2 |
7 |
9/5/2001 |
|||
T Cell Sciences, Inc. |
3,634.0 |
3 |
10/1/1989 |
|||
Targeted Genetics Corporation |
46,450.0 |
4 |
6/28/2007 |
|||
TechniScan Medical Systems, Inc. |
6,400.0 |
1 |
2/5/2007 |
|||
Tegic Communications, Inc. (AKA:T9 Text Input) |
15,000.0 |
2 |
5/4/1999 |
|||
Telefactor Corporation |
450.0 |
3 |
12/31/1998 |
|||
Telios Pharmaceuticals, Inc. |
30,530.0 |
7 |
1/1/1993 |
|||
Third Wave Technologies, Inc. |
78,064.2 |
5 |
7/26/2000 |
|||
TraceDetect, Inc. |
1,600.0 |
2 |
11/17/2003 |
|||
TransMolecular, Inc. |
42,364.3 |
4 |
2/20/2004 |
|||
Trimeris, Inc. (FKA: SL-1 Pharmaceuticals, Inc.) |
38,283.0 |
6 |
9/1/1999 |
|||
United Biomedical, Inc. |
9,000.0 |
1 |
7/1/1997 |
|||
UroCor, Inc. (FKA: CytoDiagnostics, Inc.) |
16,600.1 |
5 |
7/1/1995 |
|||
VaxGen, Inc. |
29,449.0 |
2 |
3/1/1997 |
|||
Vertex Pharmaceuticals, Inc. |
13,538.0 |
5 |
10/1/1996 |
|||
VueSonix Sensors |
4,600.0 |
3 |
7/30/2004 |
|||
Xeotron Corporation |
9,000.0 |
1 |
5/1/2001 |
|||
Xeyex Corporation |
3,267.0 |
2 |
6/30/1999 |
|||
Zynaxis, Inc.(FKA: Zynaxis Cell Science/PKH Labs) |
37,581.0 |
8 |
1/1/1995 |
|||
Martek Biosciences Corporation |
35,167.1 |
8 |
1/1/1986 |
|||
Vestar, Inc. |
34,509.1 |
15 |
7/1/1981 |
|||
Vical, Inc. |
17,850.0 |
7 |
6/1/1987 |
|||
NOTE: Hoover’s data reflect current data available through Hoover’s Small Business Database as of September 2007. SOURCES: Data on VC investments are from VentureSource; data on current and historical firms status are from Hoover’s Small Business Database (<http://www.hoovers.com>). |
First Round Date |
Status |
Ticker Symbol |
Last Known Date |
Annual Revenue (Millions of Dollars) |
Number of Employees |
Profit/Loss |
6/1/1982 |
Sold |
|
|
|
|
|
9/1/1989 |
Out of business |
|
|
|
|
|
6/12/1992 |
private |
|
|
|
|
|
1/1/1984 |
NASDAQ |
SEPR |
|
1,196.5 |
228 |
184.6 |
1/1/1993 |
private |
|
|
48.5 |
134 |
|
11/1/1979 |
NASDAQ |
SPIR |
|
20.1 |
118 |
(8.1) |
4/1/1987 |
Sold |
|
|
|
|
|
11/1/1996 |
Sold |
|
|
|
|
|
2/17/1998 |
NASDAQ |
SNSS |
|
13.7 |
138 |
|
1/1/1987 |
Sold |
|
|
|
|
|
4/1/1985 |
Out of business |
|
|
|
|
|
6/1/1992 |
NASDAQ |
TGEN |
|
9.9 |
95 |
(34.0) |
2/5/2007 |
private |
|
|
|
|
|
1/22/1998 |
Sold |
|
|
|
|
|
12/31/1997 |
Sold |
|
2000 |
|
|
|
1/1/1986 |
Sold |
|
|
|
|
|
6/30/1995 |
NASDAQ |
TWTI |
|
28.0 |
154 |
(18.9) |
3/15/2002 |
private |
|
|
1.4 |
12 |
|
9/30/1997 |
private |
|
|
1.2 |
18 |
|
2/12/1993 |
NASDAQ |
TRMS |
|
37.0 |
90 |
7.4 |
7/1/1997 |
private |
|
|
13.8 |
285 |
|
7/1/1987 |
Sold |
|
|
|
|
|
4/10/1996 |
private |
|
|
|
|
|
1/1/1989 |
NASDAQ |
TRTX |
|
216.4 |
320 |
(206.9) |
6/9/2000 |
private |
|
|
|
|
|
5/1/2001 |
Sold |
|
2004 |
|
|
|
1/1/1997 |
Out of business |
|
|
|
|
|
6/1/1988 |
Out of business |
|
|
|
|
|
2/1/2005 |
NASDAQ |
MATK |
|
270.0 |
582 |
14.9 |
7/1/1993 |
Out of business |
|
2000 |
|
|
|
3/10/1993 |
NASDAQ |
VICL |
|
14.7 |
155 |
(23.1) |